Tiziana Life Sciences – Patent Granted August 24, 2020 – Posted in: Tiziana Life Sciences (TILS)

  24th August, 2020 Tiziana Life Sciences plc  (“Tiziana” or the “Company”) Tiziana Granted a Patent on Methods and Use of Anti-IL-6/IL-6 receptor Monoclonal Antibodies as Prophylactic and Therapeutic Interventions for Covid-19 and other pulmonary diseases Tiziana Life Sciences plc (Nasdaq: TLSA; AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, announces that the United States Patent and Trademark Office (“USPTO”) has granted a patent…